English
15663 27 1

Cisplatin CAS NO.: 15663-27-1

CAS NO.:15663-27-1
Product Name: Cisplatin 
CAS No.:  15663-27-1
Form: Yellow powder, or yellow or orange-yellow crystals
Product Name: Cisplatin 
Synonyms: LEDERPLATIN;BRIPLATIN;DIAMMINEDICHLOROPLATINATE (II);CPDC;CISMAPLAT;
CAS:  15663-27-1
MF: Cl2H6N2Pt
MW:  300.04
EINECS:  239-733-8
Structure:
Email Judy@coreychem.com

Frequently Asked Questions (FAQ)

Question 1: What is Cisplatin (CAS No. 15663-27-1)?

Cisplatin is a platinum-based coordination compound widely used in cancer treatment and biomedical research. Its ability to interact with cellular DNA makes it a valuable reference compound for investigating anticancer activity and cellular responses to DNA damage.

Question 2: What are the key physical properties of Cisplatin?

Cisplatin typically appears as a yellow crystalline powder. It has limited solubility in water and should be handled according to its specified solvent compatibility. For laboratory studies, researchers should verify the product’s purity and preparation conditions before use.

Question 3: How is Cisplatin used in laboratory research?

Cisplatin is frequently used in cancer biology and pharmacology studies to evaluate cellular responses to DNA damage, investigate drug resistance, and compare potential anticancer compounds. Experimental concentrations and treatment conditions should be validated for each cell model.

Question 4: What precautions are required when handling Cisplatin?

Cisplatin is a cytotoxic substance that can pose serious health risks. Trained personnel should follow the product-specific SDS, use appropriate engineering controls and protective equipment, and collect contaminated materials as hazardous cytotoxic waste. Accidental exposure or spills must be managed under established safety procedures.

Question 5: How should Cisplatin be stored and transported?

Keep the solid product in a tightly closed, light-resistant container and protect it from moisture. Storage temperature and shipping conditions should follow the supplier’s current product specifications. Before dispatch, confirm the applicable packaging, labeling, and transport requirements for this hazardous material.

Cisplatin CAS NO.: 15663-27-1

Application 1: Cancer Cell Response and Anticancer Drug Evaluation

Cisplatin is widely used in preclinical cancer research to evaluate how tumor cells respond to DNA-damaging compounds. For example, researchers may expose cultured cancer cells to different experimental concentrations of cisplatin and assess cell viability, proliferation, and apoptosis. These results help establish a reference response for comparing investigational anticancer compounds and identifying differences in drug sensitivity.

Application 2: DNA Damage and Repair Mechanism Studies

Cisplatin can bind to DNA and form cross-links that interfere with DNA replication and transcription. In molecular biology research, it can serve as a model compound for investigating how cells recognize DNA lesions, activate damage-response pathways, and repair damaged genetic material. Researchers may compare DNA damage markers and repair-related protein expression between treated and untreated cell groups to investigate cellular repair capacity.

Application 3: Cancer Drug Resistance Research

Reduced sensitivity to cisplatin is an important research topic in oncology. Researchers can compare cisplatin-sensitive and cisplatin-resistant cancer cell models to investigate factors such as drug transport, intracellular detoxification, DNA repair activity, and apoptosis signaling. This approach helps identify biological mechanisms associated with treatment resistance and supports the evaluation of potential strategies for restoring drug sensitivity.

Application 4: Combination Therapy and Synergistic Effect Studies

Cisplatin is frequently used as a reference drug in preclinical combination studies. For example, researchers may evaluate cisplatin alongside an investigational compound to determine whether the combination produces a different cellular response from either agent alone. Cell viability measurements, apoptosis assays, and appropriate combination-analysis methods can help distinguish additive effects from potential synergy. Findings must be validated experimentally and do not automatically establish clinical benefit.

Application 5: Development and Comparison of Platinum-Based Anticancer Compounds

During early-stage drug discovery, cisplatin can provide a benchmark for evaluating newly developed platinum-containing compounds. Researchers may compare candidate compounds in terms of chemical stability, cellular uptake, cytotoxic activity, and effects on DNA damage pathways. Such comparisons can help identify candidates with different biological profiles and guide further investigation into efficacy, resistance, and toxicity.

Packaging

Package Size: 1 g/bottle

Cisplatin is supplied in a sealed bottle suitable for small-quantity laboratory and research applications. The primary container should provide effective protection against moisture and contamination, with secure secondary packaging used during transportation.

  • Net weight: 1 g per bottle

  • Primary packaging: Sealed bottle; confirm the actual container material with the supplier.

  • Secondary packaging: Protective outer packaging to help prevent breakage, leakage, and contamination during transit.

Get a quote
You can also fill out our online message form and we will contact you within 24 hours.